Repligen
RGEN
#1865
Rank
HK$85.86 B
Marketcap
HK$1,343
Share price
5.56%
Change (1 day)
15.97%
Change (1 year)
Categories

EPS for Repligen (RGEN)

EPS in 2026 (TTM): -HK$1.59

According to Repligen 's latest financial reports the company's current EPS (TTM) is -HK$1.57. In 2025 the company made an earnings per share (EPS) of HK$6.83 an increase over its 2024 EPS that were of -HK$4.00.

EPS history for Repligen from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$1.59-123.24%
2025HK$6.83-270.59%
2024-HK$4.00-168%
2023HK$5.88-77.68%
2022HK$26.3643.59%
2021HK$18.36105.26%
2020HK$8.94153.33%
2019HK$3.5318.42%
2018HK$2.98-47.95%
2017HK$5.73108.57%
2016HK$2.7520.69%
2015HK$2.2816%
2014HK$1.96-48.98%
2013HK$3.846.52%
2012HK$3.61

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$5.57-455.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
HK$149.00-9,595.00%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
HK$68.50-4,465.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$35.46-2,360.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-HK$2.98 90.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-HK$11.93 660.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$54.69-3,585.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
HK$9.18-685.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-HK$0.71-55.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
HK$8.00-610.00%๐Ÿ‡บ๐Ÿ‡ธ USA